Thursday, June 1, 2023 | Back issues
Courthouse News Service Courthouse News Service

Prescription Drug

A woman filed a federal class action against Amag Inc., claiming its high-priced drug Makena (hydroxyprogesterone caproate) did not prevent pre-term birth, as advertised, causing her baby to die shortly after birth.

JOPLIN, Mo. — A woman filed a federal class action against Amag Inc., claiming its high-priced drug Makena (hydroxyprogesterone caproate) did not prevent pre-term birth, as advertised, causing her baby to die shortly after birth.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading...